This study tested for the potential associations between maternal antenatal cannabis use disorders (CUD) and neonatal health outcomes using large linked administrative data. The study found that maternal antenatal exposure to CUD is associated with a range of adverse neonatal outcomes. This study highlights that targeted interventions focusing on antenatal counselling are recommended to mitigate risks associated with maternal cannabis use.

https://pubmed.ncbi.nlm.nih.gov/39587322/

References

  1. H. Shao, H. Du, Q. Gan, et al., “Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990–2019: Results From the Disease Burden Study 2019,” International Journal of Mental Health and Addiction 22 (2023): 2485–2507.

  2. J. Leung, G. C. K. Chan, L. Hides, and W. D. Hall, “What Is the Prevalence and Risk of Cannabis Use Disorders Among People Who Use Cannabis? A Systematic Review and Meta-Analysis,” Addictive Behaviors 109 (2020): 106479

  3. H. T. Oni, M. Buultjens, A. L. Mohamed, and M. M. Islam, “Neonatal Outcomes of Infants Born to Pregnant Women With Substance Use Disorders: A Multilevel Analysis of Linked Data,” Substance Use & Misuse 57, no. 1 (2022): 1–10.

Categories

Maternal & Infant Health  Maternal Health  Neonatal Health  Maternal/Fetal health during pregnancy  Newborn and Infants  

Tags

Reply

Please Sign in (or Register) to view further.